PROCEPT BioRobotics (PRCT) Leases (2020 - 2025)
PROCEPT BioRobotics has reported Leases over the past 6 years, most recently at $17.5 million for Q4 2025.
- Quarterly results put Leases at $17.5 million for Q4 2025, down 7.41% from a year ago — trailing twelve months through Dec 2025 was $17.5 million (down 7.41% YoY), and the annual figure for FY2025 was $17.5 million, down 7.41%.
- Leases for Q4 2025 was $17.5 million at PROCEPT BioRobotics, down from $17.9 million in the prior quarter.
- Over the last five years, Leases for PRCT hit a ceiling of $24.4 million in Q3 2022 and a floor of $2.5 million in Q2 2022.
- Median Leases over the past 5 years was $19.1 million (2024), compared with a mean of $16.4 million.
- Biggest five-year swings in Leases: dropped 29.35% in 2021 and later surged 775.48% in 2023.
- PROCEPT BioRobotics' Leases stood at $3.3 million in 2021, then surged by 592.28% to $22.7 million in 2022, then fell by 10.83% to $20.2 million in 2023, then dropped by 6.42% to $18.9 million in 2024, then dropped by 7.41% to $17.5 million in 2025.
- The last three reported values for Leases were $17.5 million (Q4 2025), $17.9 million (Q3 2025), and $18.3 million (Q2 2025) per Business Quant data.